Restoring the spinal pain gate: GABA(A) receptors as targets for novel analgesics.
暂无分享,去创建一个
Hanns Ulrich Zeilhofer | W. T. Ralvenius | H. Zeilhofer | Mario A. Acuña | William T Ralvenius | Mario A Acuña
[1] F. Knoflach,et al. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes , 2011, Nature Reviews Drug Discovery.
[2] G. Sedvall,et al. Occupancy of the central benzodiazepine receptors during benzodiazepine treatment determined by PET , 1991, European Neuropsychopharmacology.
[3] K. Sato,et al. The differential expression patterns of messenger RNAs encoding K-Cl cotransporters (KCC1,2) and Na-K-2Cl cotransporter (NKCC1) in the rat nervous system , 2001, Neuroscience.
[4] Zhi Zhang,et al. Epigenetic suppression of GAD65 expression mediates persistent pain , 2011, Nature Medicine.
[5] J. Gerven,et al. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAA α2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers , 2007 .
[6] T. Rülicke,et al. Molecular and neuronal substrate for the selective attenuation of anxiety. , 2000, Science.
[7] C. Woolf,et al. Removal of GABAergic inhibition facilitates polysynaptic A fiber-mediated excitatory transmission to the superficial spinal dorsal horn , 2003, Molecular and Cellular Neuroscience.
[8] H. Mohler,et al. Analysis of the Presence and Abundance of GABAA Receptors Containing Two Different Types of α Subunits in Murine Brain Using Point-mutated α Subunits* , 2004, Journal of Biological Chemistry.
[9] Lopez-Garcia Munro G. Comparison of the novel subtype selective GABAA receptor positive allosteric modulator NS 11394 with diazepam , zolpidem , bretazenil and gaboxadol in rat models of inflammatory and neuropathic pain , 2008 .
[10] T. Doubell,et al. Peripheral Inflammation Facilitates Aβ Fiber-Mediated Synaptic Input to the Substantia Gelatinosa of the Adult Rat Spinal Cord , 1999, The Journal of Neuroscience.
[11] Thomas Kuner,et al. Synaptic plasticity in pathological pain , 2014, Trends in Neurosciences.
[12] M. Fitzgerald,et al. Development of GABAergic and Glycinergic Transmission in the Neonatal Rat Dorsal Horn , 2004, The Journal of Neuroscience.
[13] S. Harkins,et al. Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. , 1991, Journal of craniomandibular disorders : facial & oral pain.
[14] R. Shigemoto,et al. Morphological evidence for GABA/glycine-cocontaining terminals in synaptic contact with neurokinin-1 receptor-expressing neurons in the sacral dorsal commissural nucleus of the rat , 2005, Neuroscience Letters.
[15] R. Ramakrishnan,et al. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABAA α2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers , 2008, Journal of psychopharmacology.
[16] Peter K. Zahn,et al. Peripheral and spinal GABAergic regulation of incisional pain in rats , 2012, PAIN.
[17] W. Willis,et al. Dorsal root reflexes and cutaneous neurogenic inflammation after intradermal injection of capsaicin in rats. , 1999, Journal of neurophysiology.
[18] M. Pohl,et al. Involvement of Cholecystokininergic Systems in Anxiety-Induced Hyperalgesia in Male Rats: Behavioral and Biochemical Studies , 2005, The Journal of Neuroscience.
[19] B. Komisaruk,et al. Hyperalgesia induced by altered glycinergic activity at the spinal cord. , 1985, Life sciences.
[20] S. Bohlhalter,et al. Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[21] H. Zeilhofer,et al. Gabaergic Analgesia: New Insights from Mutant Mice and Subtype- Selective Agonists , 2022 .
[22] A. Kavookjian,et al. Ultrastructural morphology, synaptic relationships, and CGRP immunoreactivity of physiologically identified c‐fiber terminals in the monkey spinal cord , 1993, The Journal of comparative neurology.
[23] Jürgen Sandkühler,et al. Models and mechanisms of hyperalgesia and allodynia. , 2009, Physiological reviews.
[24] S. Narumiya,et al. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. , 2005, The Journal of clinical investigation.
[25] T. Mexia,et al. Author ' s personal copy , 2009 .
[26] Y. Daali,et al. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain , 2011, Neuropharmacology.
[27] R. Gurrell,et al. A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain , 2011, Advances in pharmacological sciences.
[28] C. Vidal,et al. Stress hyperalgesia in rats: an experimental animal model of anxiogenic hyperalgesia in human. , 1982, Life sciences.
[29] Gonzalo Yevenes,et al. Antihyperalgesia by α2-GABAA Receptors Occurs Via a Genuine Spinal Action and Does Not Involve Supraspinal Sites , 2013, Neuropsychopharmacology.
[30] N. Mirza,et al. Positive allosteric modulation of GABA-A receptors reduces capsaicin-induced primary and secondary hypersensitivity in rats , 2012, Neuropharmacology.
[31] G. Dawson,et al. Reducing Abuse Liability of GABAA/Benzodiazepine Ligands via Selective Partial Agonist Efficacy at α1 and α2/3 Subtypes , 2010, Journal of Pharmacology and Experimental Therapeutics.
[32] H. Furue,et al. Responses to 5-HT in morphologically identified neurons in the rat substantia gelatinosa in vitro , 2009, Neuroscience.
[33] K. Hargreaves,et al. Protein expression and mRNA cellular distribution of the NKCC1 cotransporter in the dorsal root and trigeminal ganglia of the rat , 2006, Brain Research.
[34] J. Benson,et al. Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes , 1999, Nature.
[35] E. Nielsen,et al. Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain , 2008, Journal of Pharmacology and Experimental Therapeutics.
[36] Sandra M. Sanabria-Bohórquez,et al. Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist , 2011, Journal of psychopharmacology.
[37] Y. de Koninck,et al. Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain , 2007, Molecular pain.
[38] Jean-Didier Breton,et al. Production of 5α-Reduced Neurosteroids Is Developmentally Regulated and Shapes GABAA Miniature IPSCs in Lamina II of the Spinal Cord , 2004, The Journal of Neuroscience.
[39] P. Mantyh,et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. , 1999, Science.
[40] J. Fritschy,et al. Presynaptic {alpha}2-GABAA receptors in primary afferent depolarization and spinal pain control , 2011 .
[41] Yves De Koninck,et al. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain , 2003, Nature.
[42] G. Dawson,et al. TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates , 2006, Journal of Pharmacology and Experimental Therapeutics.
[43] Masahiko Watanabe,et al. Spinal Endocannabinoids and CB1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization , 2009, Science.
[44] C. Torsney,et al. Disinhibition Opens the Gate to Pathological Pain Signaling in Superficial Neurokinin 1 Receptor-Expressing Neurons in Rat Spinal Cord , 2006, The Journal of Neuroscience.
[45] E. Sigel,et al. Structure, Function, and Modulation of GABAA Receptors* , 2012, The Journal of Biological Chemistry.
[46] M. Mandelli,et al. Molecular targets for the myorelaxant action of diazepam. , 2001, Molecular pharmacology.
[47] J. Fritschy,et al. Presynaptic α2-GABAA Receptors in Primary Afferent Depolarization and Spinal Pain Control , 2011, The Journal of Neuroscience.
[48] R. F. Westbrook,et al. Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats. , 1995, Behavioral neuroscience.
[49] N Collinson,et al. An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition , 2006, Journal of Pharmacology and Experimental Therapeutics.
[50] A. Ribeiro-da-Silva,et al. Substantia Gelatinosa of the Spinal Cord , 2015 .
[51] J. Salgado,et al. Midazolam-induced hyperalgesia in rats: modulation via GABA(A) receptors at supraspinal level. , 1999, European journal of pharmacology.
[52] Kelly R. Tan,et al. Neural bases for addictive properties of benzodiazepines , 2010, Nature.
[53] H. Zeilhofer,et al. Genuine Antihyperalgesia by Systemic Diazepam Revealed by Experiments in Gaba a Receptor Point-mutated Mice , 2008 .
[54] G. Bormans,et al. MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans , 2011, Journal of psychopharmacology.
[55] L. Schnorr,et al. A new human (psycho)pharmacology tool: the multiple organs coincidences counter (MOCC) , 1995, Journal of psychopharmacology.
[56] Kay Brune,et al. Reversal of pathological pain through specific spinal GABAA receptor subtypes , 2008, Nature.
[57] B. Roth,et al. Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models. , 2009, Journal of medicinal chemistry.
[58] R. Dallel,et al. Glycine Inhibitory Dysfunction Turns Touch into Pain through PKCgamma Interneurons , 2007, PloS one.
[59] E. Sigel,et al. Positioning of the α-subunit isoforms confers a functional signature to γ-aminobutyric acid type A receptors , 2004 .
[60] S. Woods,et al. Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans. , 1999, European journal of pharmacology.
[61] C. Gravel,et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.
[62] C. Mathiasen,et al. NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy , 2008, Journal of Pharmacology and Experimental Therapeutics.
[63] N. Mirza,et al. A question of balance – Positive versus negative allosteric modulation of GABAA receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain , 2011, Neuropharmacology.
[64] J. Fritschy,et al. Selective distribution of GABAA receptor subtypes in mouse spinal dorsal horn neurons and primary afferents , 2012, The Journal of comparative neurology.
[65] M. Iyo,et al. Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography , 2004, Psychopharmacology.
[66] Gonzalo Yevenes,et al. Fast synaptic inhibition in spinal sensory processing and pain control. , 2012, Physiological reviews.
[67] Y. de Koninck,et al. Gephyrin Clusters Are Absent from Small Diameter Primary Afferent Terminals Despite the Presence of GABAA Receptors , 2014, The Journal of Neuroscience.
[68] W. Neuhuber,et al. PGE2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons , 2002, Nature Neuroscience.
[69] A. Cuello,et al. Morphological characterization of substance P‐like immunoreactive glomeruli in the superficial dorsal horn of the rat spinal cord and trigeminal subnucleus caudalis: A quantitative study , 1989, The Journal of comparative neurology.
[70] W. Sieghart,et al. Colocalization of GABA, glycine, and their receptors at synapses in the rat spinal cord , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[71] U. Rudolph,et al. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. , 2004, Annual review of pharmacology and toxicology.
[72] R. Mckernan,et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype , 2000, Nature Neuroscience.
[73] Stefan Offermanns,et al. Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia , 2004, Genesis.
[74] C. Asante,et al. The Cell and Molecular Basis of Mechanical, Cold, and Inflammatory Pain , 2008, Science.
[75] D. Kullmann,et al. Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? , 2005, Progress in biophysics and molecular biology.
[76] P. Skolnick. Anxioselective anxiolytics: on a quest for the Holy Grail. , 2012, Trends in pharmacological sciences.
[77] S. Bohlhalter,et al. Inhibitory neurotransmission in rat spinal cord: co-localization of glycine- and GABAA-receptors at GABAergic synaptic contacts demonstrated by triple immunofluorescence staining , 1994, Brain Research.
[78] R. Schmidt,et al. Presynaptic inhibition in the vertebrate spinal cord revisited , 1999, Experimental Brain Research.
[79] W. Willis,et al. Adelta and C primary afferents convey dorsal root reflexes after intradermal injection of capsaicin in rats. , 2000, Journal of neurophysiology.
[80] R. Gereau,et al. Activation of the Extracellular Signal-Regulated Kinase in the Amygdala Modulates Pain Perception , 2007, The Journal of Neuroscience.
[81] P. Rostaing,et al. Localization of components of glycinergic synapses during rat spinal cord development , 1998, The Journal of comparative neurology.
[82] J. Fritschy,et al. The α5(H105R) mutation impairs α5 selective binding properties by altered positioning of the α5 subunit in GABAA receptors containing two distinct types of α subunits , 2009, Journal of neurochemistry.
[83] B. Komisaruk,et al. Nociceptive responses to altered GABAergic activity at the spinal cord. , 1986, Life sciences.
[84] Alberto Granato,et al. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex , 2003, Nature.
[85] S. Nishi,et al. Primary afferent‐evoked glycine‐ and GABA‐mediated IPSPs in substantia gelatinosa neurones in the rat spinal cord in vitro. , 1995, The Journal of physiology.
[86] D. Fishbain,et al. Clonazepam open clinical treatment trial for myofascial syndrome associated chronic pain. , 2000, Pain medicine.
[87] Gonzalo Yevenes,et al. Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control. , 2012, Annual review of pharmacology and toxicology.
[88] H. Wässle,et al. GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization , 2004, Science.
[89] H. Zeilhofer,et al. Fast Inhibitory Transmission of Pain in the Spinal Cord , 2009 .
[90] Y. Koninck,et al. Region-Specific Developmental Specialization of GABA–Glycine Cosynapses in Laminas I–II of the Rat Spinal Dorsal Horn , 2001, The Journal of Neuroscience.
[91] L. Arendt-Nielsen,et al. Evaluation of Anti-Hyperalgesic and Analgesic Effects of Two Benzodiazepines in Human Experimental Pain: A Randomized Placebo-Controlled Study , 2013, PloS one.
[92] A. Todd,et al. Light microscope study of the coexistence of GABA‐like and glycine‐like immunoreactivities in the spinal cord of the rat , 1990, The Journal of comparative neurology.
[93] T. Sejnowski,et al. Reduction of anion reversal potential subverts the inhibitory control of firing rate in spinal lamina I neurons: towards a biophysical basis for neuropathic pain. , 2006, Molecular pain.
[94] A. Ribeiro-da-Silva,et al. Distribution of glomeruli with fluoride-resistant acid phosphatase (FRAP)-containing terminals in the substantia gelatinosa of the rat , 1986, Brain Research.
[95] P. Wall,et al. Pain mechanisms: a new theory. , 1965, Science.
[96] Hiroshi Baba,et al. Partial Peripheral Nerve Injury Promotes a Selective Loss of GABAergic Inhibition in the Superficial Dorsal Horn of the Spinal Cord , 2002, The Journal of Neuroscience.
[97] G. Dawson,et al. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[98] Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats. , 1995, Behavioral neuroscience.